APPTECH PAYMENTS CORP (APCX)

US03834B3096 - Common Stock

0.62  +0.24 (+62.73%)

Premarket: 0.6337 +0.01 (+2.21%)

Fundamental Rating

1

APCX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 99 industry peers in the Financial Services industry. APCX has a bad profitability rating. Also its financial health evaluation is rather negative. APCX does not seem to be growing, but still is valued expensively.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

APCX had negative earnings in the past year.
In the past year APCX has reported a negative cash flow from operations.
APCX had negative earnings in each of the past 5 years.
In the past 5 years APCX always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -172.15%, APCX is not doing good in the industry: 98.99% of the companies in the same industry are doing better.
APCX's Return On Equity of -813.87% is on the low side compared to the rest of the industry. APCX is outperformed by 96.97% of its industry peers.
Industry RankSector Rank
ROA -172.15%
ROE -813.87%
ROIC N/A
ROA(3y)-469.69%
ROA(5y)-837.34%
ROE(3y)-66268%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 78.90%, APCX belongs to the best of the industry, outperforming 86.87% of the companies in the same industry.
In the last couple of years the Gross Margin of APCX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for APCX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.99%
GM growth 5Y0.95%

More info and screens

2

2. Health

2.1 Basic Checks

APCX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for APCX has been increased compared to 1 year ago.
Compared to 5 years ago, APCX has more shares outstanding
Compared to 1 year ago, APCX has an improved debt to assets ratio.

2.2 Solvency

APCX has an Altman-Z score of -39.92. This is a bad value and indicates that APCX is not financially healthy and even has some risk of bankruptcy.
APCX has a worse Altman-Z score (-39.92) than 81.82% of its industry peers.
APCX has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
APCX's Debt to Equity ratio of 0.05 is amongst the best of the industry. APCX outperforms 83.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -39.92
ROIC/WACCN/A
WACC14.04%

2.3 Liquidity

APCX has a Current Ratio of 0.06. This is a bad value and indicates that APCX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.06, APCX is doing worse than 79.80% of the companies in the same industry.
A Quick Ratio of 0.06 indicates that APCX may have some problems paying its short term obligations.
APCX has a worse Quick ratio (0.06) than 79.80% of its industry peers.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06

More info and screens

2

3. Growth

3.1 Past

APCX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.28%, which is quite impressive.
The Revenue for APCX has decreased by -22.34% in the past year. This is quite bad
The Revenue has been growing by 15.05% on average over the past years. This is quite good.
EPS 1Y (TTM)57.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.47%
Revenue 1Y (TTM)-22.34%
Revenue growth 3Y15.16%
Revenue growth 5Y15.05%
Sales Q2Q%-71.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y70.3%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1287.72%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

APCX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year APCX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

APCX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

APPTECH PAYMENTS CORP

NASDAQ:APCX (12/19/2024, 10:12:06 PM)

Premarket: 0.6337 +0.01 (+2.21%)

0.62

+0.24 (+62.73%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)N/A N/A
Inst Owners4.68%
Inst Owner Change0.25%
Ins Owners103.26%
Ins Owner Change0%
Market Cap17.14M
Analysts82.86
Price Target1.53 (146.77%)
Short Float %0.87%
Short Ratio1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.38%
Min EPS beat(2)-30.72%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-8.25%
Min EPS beat(4)-30.72%
Max EPS beat(4)1.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-73.25%
Min Revenue beat(2)-98.25%
Max Revenue beat(2)-48.26%
Revenue beat(4)0
Avg Revenue beat(4)-44.12%
Min Revenue beat(4)-98.25%
Max Revenue beat(4)-1.96%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 46.97
P/FCF N/A
P/OCF N/A
P/B 12.25
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0.01
BVpS0.05
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -172.15%
ROE -813.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.9%
FCFM N/A
ROA(3y)-469.69%
ROA(5y)-837.34%
ROE(3y)-66268%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.99%
GM growth 5Y0.95%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.58%
Cap/Sales 138.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z -39.92
F-Score4
WACC14.04%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)244.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.47%
EPS Next Y70.3%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.34%
Revenue growth 3Y15.16%
Revenue growth 5Y15.05%
Sales Q2Q%-71.43%
Revenue Next Year1287.72%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.81%
OCF growth 3YN/A
OCF growth 5YN/A